Search - tctmd.com

Displaying 221 - 240 of 647

Sort: Relevancy | Date

Debate: Is a Clinical Outcomes Trial Mandatory Before Widespread Adoption of Device-Based Hypertension Therapies? - Yes, An Outcomes Study for Device-Based Hypertension Approaches Is Needed Before Widespread Use Can Be Recommended!

Presentation TCT 2019

Yes, An Outcomes Study for Device-Based Hypertension Approaches Is Needed Before Widespread Use Can Be Recommended!

Presenter: Bernard Gersh

September 28, 2019

Debate: Is a Clinical Outcomes Trial Mandatory Before Widespread Adoption of Device-Based Hypertension Therapies? - No: An Outcomes Study for Device-Based Hypertension Approaches Is NOT Necessary Before Widespread Use Can Be Recommended!

Presentation TCT 2019

No: An Outcomes Study for Device-Based Hypertension Approaches Is NOT Necessary Before Widespread Use Can Be Recommended!

Presenter: Andrew Sharp

September 28, 2019

Presentation TCT 2019

Device-Based Hypertension Treatments: Defining Responders and Predictors of Response

Presenter: Naomi Fisher

September 28, 2019

Presentation TCT 2019

Backbeat Update (Pacemaker-Mediated Baroreflex Stimulation)

Presenter: Daniel Burkhoff

September 28, 2019

Presentation TCT 2019

Update on ROX Trial Program (AV Fistula Creation)

Presenter: Melvin Lobo

September 28, 2019

Presentation TCT 2019

Update on CALM-II Trial (Endovascular Baroreflex Stimulation)

Presenter: Gregg Stone

September 28, 2019

Presentation TCT 2019

Magnitude of Antihypertensive Effect After Renal Denervation: Is It Sufficient for High-Risk as Well as Low-Risk Patients?

Presenter: Justin Davies

September 28, 2019

Presentation TCT 2019

Update on Target BP Trials Program (Chemical Renal Denervation): Lessons Learned, Ongoing Efforts

Presenter: Felix Mahfoud

September 28, 2019

Presentation TCT 2019

Update on RADIANCE Trials Program (Ultra-Sound Renal Denervation): Lessons Learned, Ongoing Efforts

Presenter: Ajay Kirtane

September 28, 2019

Presentation TCT 2019

Update on SPRYRAL Trials Program (Radiofrequency Renal Denervation): Lessons Learned, Ongoing Efforts

Presenter: Michael Boehm

September 28, 2019

Presentation TCT 2019

Patient Preferences in Hypertension Treatment

Presenter: David Kandzari

September 28, 2019

Presentation TCT 2019

Non-Adherence in Uncontrolled Hypertension: How to Assess and Manage?

Presenter: Roland Schmieder

September 28, 2019

News Conference News TCT 2019

Surgical Volume Matters When It Comes to Repair of Primary MR

Todd Neale

September 28, 2019

Presentation TCT 2019

Race-Based Differences in Hypertension Management: What’s Relevant?

Presenter: Clyde Yancy

September 28, 2019

Presentation TCT 2019

Sex-Based Differences in Hypertension Management: Do They Exist?

Presenter: Ileana Pina

September 28, 2019

Presentation TCT 2019

The Essentials of Blood Pressure Measurement: Office, Home, and Ambulatory — And Why It Matters

Presenter: Michael Weber

September 28, 2019

Presentation TCT 2019

In Case You Missed It: What’s Happened (So Very) Recently in Renal Denervation

Presenter: Andrew Sharp

September 28, 2019

Presentation TCT 2019

Clinical Context of SOLO and Future Results and Implications for Who to Treat

Presenter: Naomi Fisher

September 27, 2019

Presentation TCT 2019

RADIANCE-HTN SOLO: In-Depth Analysis at 6 Months After Medication Titration and Review of RADIANCE-HTN Global Clinical Trial Program

Presenter: Ajay Kirtane

September 27, 2019

Presentation TCT 2019

RDN Procedure With the ReCor Paradise Technology: Anatomy, Treatment Location, Procedure Standardization and Simplicity

Presenter: Chandan Devireddy

September 27, 2019

Advertisement

Yes, An Outcomes Study for Device-Based Hypertension Approaches Is Needed Before Widespread Use Can Be Recommended!

No: An Outcomes Study for Device-Based Hypertension Approaches Is NOT Necessary Before Widespread Use Can Be Recommended!

Device-Based Hypertension Treatments: Defining Responders and Predictors of Response

Backbeat Update (Pacemaker-Mediated Baroreflex Stimulation)

Update on ROX Trial Program (AV Fistula Creation)

Update on CALM-II Trial (Endovascular Baroreflex Stimulation)

Magnitude of Antihypertensive Effect After Renal Denervation: Is It Sufficient for High-Risk as Well as Low-Risk Patients?

Update on Target BP Trials Program (Chemical Renal Denervation): Lessons Learned, Ongoing Efforts

Update on RADIANCE Trials Program (Ultra-Sound Renal Denervation): Lessons Learned, Ongoing Efforts

Update on SPRYRAL Trials Program (Radiofrequency Renal Denervation): Lessons Learned, Ongoing Efforts

Patient Preferences in Hypertension Treatment

Non-Adherence in Uncontrolled Hypertension: How to Assess and Manage?

Surgical Volume Matters When It Comes to Repair of Primary MR

Race-Based Differences in Hypertension Management: What’s Relevant?

Sex-Based Differences in Hypertension Management: Do They Exist?

The Essentials of Blood Pressure Measurement: Office, Home, and Ambulatory — And Why It Matters

In Case You Missed It: What’s Happened (So Very) Recently in Renal Denervation

Clinical Context of SOLO and Future Results and Implications for Who to Treat

RADIANCE-HTN SOLO: In-Depth Analysis at 6 Months After Medication Titration and Review of RADIANCE-HTN Global Clinical Trial Program

RDN Procedure With the ReCor Paradise Technology: Anatomy, Treatment Location, Procedure Standardization and Simplicity

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content